We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.6B
AUM Growth
-$234M
Cap. Flow
-$434M
Cap. Flow %
-4.08%
Top 10 Hldgs %
11.4%
Holding
561
New
183
Increased
121
Reduced
99
Closed
141

Top Buys

Rank Stock Value
1
WFM
Whole Foods Market Inc
WFM
+$119M
2
BAX icon
Baxter International
BAX
+$107M
3
ABT icon
Abbott
ABT
+$103M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$103M
5
KHC icon
Kraft Heinz
KHC
+$92.4M

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$176M
2
CSCO icon
Cisco
CSCO
+$151M
3
CELG
Celgene Corp
CELG
+$148M
4
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$145M
5
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$135M

Sector Composition

Rank Sector Weight
1 Healthcare 17.9%
2 Technology 14.54%
3 Industrials 10.72%
4 Consumer Discretionary 10.71%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGN
376
DELISTED
Aceragen Inc
ACGN
$1.29M 0.01%
6,225
+126
+2% +$27.8K
SYRS
377
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.27M 0.01%
+7,000
New +$1.27M
MBT
378
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$1.24M 0.01%
+150,000
New +$1.33M
SNDX icon
379
Syndax Pharmaceuticals
SNDX
$1.82B
$1.23M 0.01%
125,000
-50,000
-29% -$686K
RLYP
380
DELISTED
RELYPSA INC COM
RLYP
$1.19M 0.01%
64,250
+1,306
+2% +$22.9K
PHH
381
DELISTED
PHH Corporation
PHH
$1.19M 0.01%
+89,023
New +$1.15M
RPAI
382
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$1.11M 0.01%
+65,654
New +$1.06M
TBCH
383
Turtle Beach Corp
TBCH
$277M
$1.1M 0.01%
282,756
-13,028
-4% -$53.5K
ESTE
384
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$1.08M 0.01%
+100,000
New +$1.23M
RPT
385
Rithm Property Trust
RPT
$93.7M
$1.08M 0.01%
+13,386
New +$1.04M
CLSD
386
DELISTED
Clearside Biomedical
CLSD
$1.05M 0.01%
+10,000
New +$1.05M
CLGX
387
DELISTED
Corelogic, Inc.
CLGX
$983K 0.01%
+25,539
New +$933K
LRMR icon
388
Larimar Therapeutics
LRMR
$432M
$946K 0.01%
13,166
+267
+2% +$21.1K
ATRS
389
DELISTED
Antares Pharma, Inc.
ATRS
$910K 0.01%
866,810
+17,586
+2% +$17K
HRI icon
390
Herc Holdings
HRI
$5.61B
$901K 0.01%
+27,120
New +$779K
WINT
391
DELISTED
Windtree Therapeutics Inc
WINT
$896K 0.01%
464,241
+9,420
+2% +$22.8K
GNCA
392
DELISTED
Genocea Biosciences, Inc.
GNCA
$881K 0.01%
26,858
+545
+2% +$20K
PLCM
393
DELISTED
POLYCOM INC
PLCM
$810K 0.01%
+72,000
New +$840K
NGNE icon
394
Neurogene
NGNE
$712M
$781K 0.01%
5,899
+120
+2% +$19.1K
TDY icon
395
Teledyne Technologies
TDY
$32B
$762K 0.01%
+7,696
New +$728K
VTVT icon
396
vTv Therapeutics
VTVT
$139M
$762K 0.01%
3,283
+67
+2% +$15.4K
RXII
397
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$743K 0.01%
1,593,277
– –
VNCE icon
398
Vince Holding Corp
VNCE
$86.8M
$679K 0.01%
12,399
+4,715
+61% +$275K
DARE icon
399
Dare Bioscience
DARE
$21M
$677K 0.01%
2,661
+54
+2% +$17.3K
GNMX
400
DELISTED
Aevi Genomic Medicine Inc
GNMX
$555K 0.01%
+100,000
New +$525K
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2016 Portfolio in Review

As of Q2 2016, Alyeska Investment Group held 561 positions worth $10.6B, down 2.2% from $10.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group withdrew a net $434M in Q2 2016, closing 141 positions and reducing 99 holdings. Its most notable exit was Cisco, an estimated $151M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Baxter International worth $111M.

  • Alyeska Investment Group's largest Q2 2016 buy was Baxter International: 2,450,018 shares worth $111M.
  • Alyeska Investment Group added most to Whole Foods Market Inc in Q2 2016, an estimated $119M increase.
  • Alyeska Investment Group's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $176M.
  • Alyeska Investment Group fully exited Cisco in Q2 2016, selling an estimated $151M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $10.6B portfolio in Q2 2016.
  • Alyeska Investment Group opened 183 new positions and closed 141 in Q2 2016.
  • Alyeska Investment Group's portfolio value fell 2.2% quarter-over-quarter to $10.6B.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.